| Autor: |
Raad, Issam, Hachem, Ray, Hanna, Hend, Girgawy, Essam, Rolston, Kenneth, Whimbey, Estella, Husni, Rola, Bodey, Gerald |
| Zdroj: |
Antimicrobial Agents and Chemotherapy; November 2001, Vol. 45 Issue: 11 p3202-3204, 3p |
| Abstrakt: |
ABSTRACTBetween February 1994 and November 1998, 56 oncology patients infected with vancomycin-resistant enterococci (VRE) were treated with quinopristin-dalfopristin (Q-D) plus minocycline (MIN). Infections included bacteremia, urinary tract infection, pneumonia, and wound infection. The response rate was 68%, and the most frequent adverse event was arthralgia or myalgia (36%). Q-D–MIN is effective for VRE infection in cancer patients but is associated with a substantial frequency of arthralgia or myalgia. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
